MX2015006599A - Sequences of synthetic deoxyribonucleic acids and heterologous recombinant proteins of the haemagglutinin of the influenza virus expressed in chlamydomonas reinhardtii chloroplast, and use thereof in vaccines. - Google Patents

Sequences of synthetic deoxyribonucleic acids and heterologous recombinant proteins of the haemagglutinin of the influenza virus expressed in chlamydomonas reinhardtii chloroplast, and use thereof in vaccines.

Info

Publication number
MX2015006599A
MX2015006599A MX2015006599A MX2015006599A MX2015006599A MX 2015006599 A MX2015006599 A MX 2015006599A MX 2015006599 A MX2015006599 A MX 2015006599A MX 2015006599 A MX2015006599 A MX 2015006599A MX 2015006599 A MX2015006599 A MX 2015006599A
Authority
MX
Mexico
Prior art keywords
haemagglutinin
sequences
influenza virus
recombinant proteins
vaccines
Prior art date
Application number
MX2015006599A
Other languages
Spanish (es)
Inventor
Rosales Mendoza Sergio
Alejandro Castellanos Huerta Inkar
Bañuelos Hernández Bernardo
Gabriel Brieba De Castro Luis
Tellez Isaias Guillermo
Fernandez Siurob Isidro
Original Assignee
Viren S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viren S A De C V filed Critical Viren S A De C V
Priority to MX2015006599A priority Critical patent/MX2015006599A/en
Priority to PCT/MX2016/000040 priority patent/WO2016186483A1/en
Publication of MX2015006599A publication Critical patent/MX2015006599A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention describes sequences of synthetic haemagglutinin nucleotides of the avian influenza virus, more specifically haemagglutinin type 5, characterised by being codon-optimised for correct genetic expression in the Chlamydomonas reinhardtii chloroplast; the codified recombinant proteins codified by these nucleotide sequences, and their use or application in the vaccination of animals and humans.
MX2015006599A 2015-05-19 2015-05-19 Sequences of synthetic deoxyribonucleic acids and heterologous recombinant proteins of the haemagglutinin of the influenza virus expressed in chlamydomonas reinhardtii chloroplast, and use thereof in vaccines. MX2015006599A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2015006599A MX2015006599A (en) 2015-05-19 2015-05-19 Sequences of synthetic deoxyribonucleic acids and heterologous recombinant proteins of the haemagglutinin of the influenza virus expressed in chlamydomonas reinhardtii chloroplast, and use thereof in vaccines.
PCT/MX2016/000040 WO2016186483A1 (en) 2015-05-19 2016-04-26 Sequences of synthetic deoxyribonucleic acids and heterologous recombinant proteins of the haemagglutinin of the influenza virus expressed in chlamydomonas reinhardtii chloroplast, and use thereof in vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2015006599A MX2015006599A (en) 2015-05-19 2015-05-19 Sequences of synthetic deoxyribonucleic acids and heterologous recombinant proteins of the haemagglutinin of the influenza virus expressed in chlamydomonas reinhardtii chloroplast, and use thereof in vaccines.

Publications (1)

Publication Number Publication Date
MX2015006599A true MX2015006599A (en) 2016-11-18

Family

ID=57320758

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015006599A MX2015006599A (en) 2015-05-19 2015-05-19 Sequences of synthetic deoxyribonucleic acids and heterologous recombinant proteins of the haemagglutinin of the influenza virus expressed in chlamydomonas reinhardtii chloroplast, and use thereof in vaccines.

Country Status (2)

Country Link
MX (1) MX2015006599A (en)
WO (1) WO2016186483A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007022425A2 (en) * 2005-08-16 2007-02-22 Hawaii Biotech, Inc. Influenza recombinant subunit vaccine
EP1925318A1 (en) * 2006-11-20 2008-05-28 Paul-Ehrlich-Institut Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu

Also Published As

Publication number Publication date
WO2016186483A1 (en) 2016-11-24

Similar Documents

Publication Publication Date Title
DK3523430T3 (en) MANIPULATED NUCLEIC ACID TARGETED NUCLEIC ACIDS
BR112018003019A2 (en) hpv18 therapeutic vaccines
AR103226A1 (en) HAPLOID INDUCTOR
PH12019500209A1 (en) Methods and compositions for gene expression in plants
BR112017003406A2 (en) chromobacterium subtsugae genome
MX2018008135A (en) Influenza nucleic acid molecules and vaccines made therefrom.
PH12017500679A1 (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
MX2017007105A (en) Lipase variants and polynucleotides encoding same.
BR112016017723A2 (en) pteris vittata phytase nucleotide and amino acid sequences and methods of use
MX2021013879A (en) Lipase variants and polynucleotides encoding same.
WO2020061443A3 (en) Methods of making and using universal centralized influenza vaccine genes
CL2018003875A1 (en) Fish virus
EP3448407A4 (en) Dimeric proteins for specific targeting of nucleic acid sequences
MX2018005872A (en) Nucleic acid prodrugs.
MX2019004183A (en) Nucleotide sequence expressing an exosome-anchoring protein for use as vaccine.
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
BR112017003228A2 (en) chromobacterium subtsugae genes
WO2015123592A3 (en) Recombinant rna particles and methods of use
CL2015003242A1 (en) Aav / upr-plus virus, upr-plus fusion protein, genetic treatment method and its use in the treatment of neurodegenerative diseases, such as parkinson's and huntington diseases, among others.
MX2015006599A (en) Sequences of synthetic deoxyribonucleic acids and heterologous recombinant proteins of the haemagglutinin of the influenza virus expressed in chlamydomonas reinhardtii chloroplast, and use thereof in vaccines.
MX360137B (en) H5 proteins of h5n1 influenza virus for use as a medicament.
PL410572A1 (en) DNA aptamer recognizing human PCNA protein and its application
AR105066A1 (en) ENZYMES AND CRISPR SYSTEMS
BR112017000146A2 (en) recombinant microorganism of the genus escherichia producing quinolinic acid, and method of producing quinolinic acid
TH169592A (en) Protein fusion and methods for plant growth stimulation, plant protection, and fixation of BACILLUS spores on plants.

Legal Events

Date Code Title Description
HH Correction or change in general